KRAS G12C-mutated Solid Tumors, Lung Cancer trials recruiting in New York

Fewer than 3 recruiting trials found.

All KRAS G12C-mutated Solid Tumors, Lung Cancer trials nationally

Cities in New York

Recruiting trials in New York

• Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
  NCT06162221 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · New York: New York, Westbury